🕵️ GYRE Therapeutics, Inc. ($GYRE)
SEC insider & ownership activity, last 12 months · CIK 1124105 · every row links its SEC filing
Over the last 12 months insiders sold $953K with no open-market buying against it. Ye Weiguo sold $870K (May–Jun). No red-flag 8-Ks in the window.
🚨 1 signal active —
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 2 sellers, $953K (18 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Ye Weiguo | 0 | – | 16 | $870K | Jun 18, 2026 |
| Luo Ying | 0 | – | 2 | $83K | May 6, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| GNI USA, Inc. | 69.1% | 13D | May 4, 2026 | filing ↗ | |
| GNI Group Ltd. | 69.1% | 13D | May 4, 2026 | filing ↗ | |
| Ping Lan | 8.6% | 13D | May 4, 2026 | filing ↗ | |
| Ying Luo | 8.6% | 13D | May 4, 2026 | filing ↗ | |
| Yueying Zhu | 6.3% | 13D | May 4, 2026 | filing ↗ | |
| Songjiang Ma | 6.3% | 13D | May 4, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Ye Weiguo | $2.1M | May 13, 2026 | filing ↗ |
| Ye Weiguo | $4.6M | Nov 15, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jul 10, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 10, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 10, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 1, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 14, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 12, 2026 | filing ↗ |
| Earnings (2.02) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Earnings (2.02) | May 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 4, 2026 | filing ↗ |
| Acquisition or disposition (2.01) | May 4, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | May 4, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | May 4, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 4, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | May 4, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 4, 2026 | filing ↗ |
| Other events (8.01) | Mar 22, 2026 | filing ↗ |
| Earnings (2.02) | Mar 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 12, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 10, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 2, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 2, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Mar 2, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 2, 2026 | filing ↗ |